Recombinant Human PTP4A1 Protein，His

PTP4A1, also known as protein tyrosine phosphatase 4A1, is part of a small family of tyrosine phosphatases that play crucial roles in various cellular processes, including cell growth, differentiation, and signaling pathways. Research has shown that PTP4A1 is overexpressed in several types of cancer, including breast, colorectal, and gastric cancers, indicating its potential role in tumor development and progression. Its enzymatic activity is associated with the dephosphorylation of tyrosine residues on target proteins, which can influence oncogenic signaling pathways such as those mediated by growth factors. Given its involvement in cancer biology, PTP4A1 has emerged as a promising target for therapeutic intervention. The study of its recombinant protein form facilitates the understanding of its enzymatic mechanism, interaction with substrates, and the identification of potential inhibitors. Structural analyses, alongside biochemical characterization, can elucidate the functional aspects of PTP4A1 and its role in malignant transformation. By exploring its expression patterns and functional implications, researchers aim to unravel its contribution to cancer pathology and develop novel strategies for diagnosis and treatment, potentially leveraging PTP4A1 as a biomarker for cancer progression or as a target for drug development. Overall, the investigation of PTP4A1 recombinant protein is critical for advancing our knowledge of its biological functions and therapeutic potential in oncology.